| Metric | Q2 2026 | Q2 2025 |
|---|---|---|
| Revenue | 99.5 | 83.0 |
| Gross profit | 23.4 | 21.9 |
| Profit before tax | -41.5 | -4.8 |
| Net income | -40.7 | -5.0 |
| EPS (diluted, $ a share) | $-0.10 | $-0.02 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +19.9% |
|---|---|
| Gross margin | 23.5% |
| Operating margin | -23.1% |
10-Q filed with the SEC, NASDAQ: CGC. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Canopy Growth Corp: key numbers
- Share price
- $0.5460Close, Nov 16
- Market cap
- $231M
- Shares outstanding
- 423.35MLatest SEC cover page
- Sector
- Life Sciences
- Industry
- Medicinal Chemicals & Botanical ProductsSIC 2833
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Canopy Growth Corp
All →Canopy Growth Financial Results
Canopy Growth reported Q2 FY2027 consolidated net revenue of $81.4M, a 22% year-over-year increase driven by 141% growth in international markets. The company saw strong performance in its cannabis segment, particularly in Germany and Poland, and is targeting positive adjusted EBITDA during fiscal 2027.
- Term
- Q2 2027
“We have made tremendous progress on our international strategy. Our international business delivered 141% net revenue growth in the second quarter of fiscal year 2027 driven by strong medical cannabis sales in Germany and Poland.”
Luc Mongeau, Chief Executive Officer
“We reported another quarter of strong net revenue growth, including a 17% year-over-year increase in Canada adult-use cannabis, an 18% increase in Canada medical cannabis and 30% growth in the Cannabis segment overall. We are progressing steadily to profitability, quarter after quarter.”
Tom Stewart, Chief Financial Officer
Canopy Growth Reverse Stock Split
Canopy Growth shareholders approved a special resolution at the 2026 Annual General and Special Meeting to authorize a reverse stock split. The Board has the discretion to consolidate common and exchangeable shares at a ratio between 1-for-5 and 1-for-15 at any time prior to September 25, 2027.
Canopy Growth Nasdaq/NYSE Compliance Notice
Canopy Growth Corporation received a deficiency notice from Nasdaq on October 14, 2026, because its common shares closed below the $1.00 minimum bid price for 30 consecutive business days. The company has until April 12, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for ten consecutive business days. Canopy Growth is currently seeking shareholder approval for a potential reverse stock split at its upcoming annual meeting to address the deficiency.
- Counterparty
- Nasdaq
- Term
- 180 days
Canopy Growth Insider Theresa Yanofsky Sells $13.8K of Stock
Theresa Yanofsky sold 14,920 shares of Canopy Growth Corp at $0.9268 a share, worth $13.8K in total on Sep 28, 2026. Shares held after the trade: 131,495 (-10.2%).
- Value
- $13.8K
- Shares
- 14,920
- Price
- $0.9268
- Holding change
- -10.2%
- Trade date
- Sep 28, 2026
Canopy Growth Insider David Angelo Lazzarato Sells $20.7K of Stock
David Angelo Lazzarato sold 22,380 shares of Canopy Growth Corp at $0.9268 a share, worth $20.7K in total on Sep 28, 2026. Shares held after the trade: 189,479 (-10.6%).
- Value
- $20.7K
- Shares
- 22,380
- Price
- $0.9268
- Holding change
- -10.6%
- Trade date
- Sep 28, 2026